Literature DB >> 6992550

Giant cell (cranial) arteritis: a clinical review.

K A Huston, G G Hunder.   

Abstract

Giant cell arteritis is a disease of the elderly which is more common than previously recognized. It is important to be aware of this condition because treatment effectively relieves symptoms and prevents serious complications. The disease is suggested when an elderly patient complains of constitutional symptoms, headache, jaw claudication, or the musculoskeletal manifestations of polymyalgia rheumatica. Abnormalities in temporal arteries or other cranial arteries, or evidence of large vessel involvement may be detected by physical examination. A markedly elevated sedimentation rate in association with other clinical features of the disease strongly suggests giant cell arteritis, but a biopsy should be performed to confirm the diagnosis. Corticosteroid therapy should be started promptly in high doses in order to prevent blindness. Prolonged treatment with lower dose corticosteroids is generally necessary for up to 1 to 2 years, and sometimes longer, for continued symptomatic relief. Long-term follow-up of treated patients has demonstrated no detectable effect on survivorship.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 6992550     DOI: 10.1016/0002-8703(80)90285-9

Source DB:  PubMed          Journal:  Am Heart J        ISSN: 0002-8703            Impact factor:   4.749


  7 in total

Review 1.  Stopping steroids in polymyalgia rheumatica and giant cell arteritis.

Authors:  V Kyle; B L Hazelman
Journal:  BMJ       Date:  1990-02-10

2.  Treatment of polymyalgia rheumatica and giant cell arteritis. I. Steroid regimens in the first two months.

Authors:  V Kyle; B L Hazleman
Journal:  Ann Rheum Dis       Date:  1989-08       Impact factor: 19.103

3.  Pulmonary function of nonsmoking patients with giant cell arteritis and/or polymyalgia rheumatica; a controlled study.

Authors:  N C Acritidis; A P Andonopoulos; V Galanopoulou; A A Drosos; S H Constantopoulos
Journal:  Clin Rheumatol       Date:  1988-06       Impact factor: 2.980

4.  Giant cell arteritis of the skin simulating erythema nodosum.

Authors:  J W Goldberg; M L Lee; S M Sajjad
Journal:  Ann Rheum Dis       Date:  1987-09       Impact factor: 19.103

5.  Giant cell arteritis and normal pressure hydrocephalus. A case report.

Authors:  F Girotti; S Lodrini; M P Grassi; A Allegranza
Journal:  Ital J Neurol Sci       Date:  1984-03

6.  The ESR in the diagnosis and management of the polymyalgia rheumatica/giant cell arteritis syndrome.

Authors:  M E Ellis; S Ralston
Journal:  Ann Rheum Dis       Date:  1983-04       Impact factor: 19.103

7.  Can methotrexate be used as a steroid sparing agent in the treatment of polymyalgia rheumatica and giant cell arteritis?

Authors:  M J van der Veen; H J Dinant; C van Booma-Frankfort; G A van Albada-Kuipers; J W Bijlsma
Journal:  Ann Rheum Dis       Date:  1996-04       Impact factor: 19.103

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.